LABETALOL HYDROCHLORIDE INJECTION USP
JAMP PHARMA CORPORATION
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LABETALOL HYDROCHLORIDE INJECTION USP in Canada?
Yes. LABETALOL HYDROCHLORIDE INJECTION USP 5MG has an active shortage reported to Health Canada (last updated September 23, 2026).
Why is LABETALOL HYDROCHLORIDE INJECTION USP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will LABETALOL HYDROCHLORIDE INJECTION USP be available again?
The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LABETALOL HYDROCHLORIDE INJECTION USP
SANDOZ CANADA INCORPORATED
Other Products
TRANDATE INJ 5MG/ML
GLAXO CANADA INC
TRANDATE 5MG/ML
SHIRE BIOCHEM INC
LABETALOL HYDROCHLORIDE INJECTION IN 5% DEXTROSE
HIKMA CANADA LIMITED
LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE
HIKMA CANADA LIMITED
TRANDATE TAB 200MG
GLAXO CANADA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-10-16
~18 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02541505
Strength
5MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
LABETALOL HYDROCHLORIDE
Tier
Unrated
Last Updated
2026-09-23
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164